{"filings":[{"id":527316,"accession_number":"0001156375-26-000028","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-05-19T20:21:13+00:00","items":["5.07"],"status":"ready","headline":"CME Group adjourns four proposals due to Class B quorum shortfall; elects all director nominees","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Class B-1 through B-4 failed quorum (33.3% required); only 24-33% present. Proposals 4-8 adjourned to June 9, 2026 virtual meeting.","14 equity directors elected; Terrence A. Duffy received 267.9M for, 26.6M against, 459.9K abstain.","Ratification of Ernst & Young as auditor approved: 291.4M for, 26.6M against, 494.6K abstain.","Advisory say-on-pay approved: 259.6M for, 34.5M against, 854.3K abstain; 23.5M broker non-votes.","Total shares outstanding 362.8M; overall quorum 87.78% due to Class A presence."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91574,"accession_number":"0001156375-26-000022","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-04-27T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"CME Group subsidiary amends $7B clearing house credit facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 11 to 364-day multi-currency revolving secured credit facility, dated April 22, 2026.","Facility size remains $7B with accordion feature to increase to $10B.","Proceeds used for temporary liquidity in clearing firm default, depositary default, or payment system disruption.","Collateral includes cash, U.S. Treasury securities, and performance bond assets.","Facility requires CME to maintain a consolidated tangible net worth test."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91573,"accession_number":"0001156375-26-000016","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group files 8-K for Q1 2026 earnings; press release exhibit not provided in input","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Furnished quarterly financial results for quarter ended March 31, 2026.","Exhibit 99.1 press release text is missing; specific figures are unavailable.","No guidance, segment data, or non-GAAP adjustments can be extracted.","Investors should refer to the full press release on the company's website."],"consensus_eps_estimate":null,"consensus_eps_actual":3.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":1880100000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101768,"accession_number":"0001156375-26-000006","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q4 2025 adjusted EPS $2.68, revenue $1.8B; 2026 dividend raised 10% to $1.30/quarter","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $1.8B (+20% YoY), record full-year revenue $7.1B (+35%).","Q4 adjusted EPS $2.68 (+29% YoY); full-year adjusted EPS $10.67.","Record Q4 average daily volume 28.4M contracts (+36%); full-year ADV 27.8M (+31%).","Board authorizes 10% dividend increase to $1.30/quarter beginning Q1 2026.","Adjusted operating expenses Q4 $712M (+20%), driven by higher compensation and tech."],"consensus_eps_estimate":null,"consensus_eps_actual":11.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":6520600000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101767,"accession_number":"0001156375-26-000002","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Group Announces Pricing Changes via Special Executive Report 9676","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["On February 2, 2026, CME Group communicated pricing changes to clients in Special Executive Report 9676.","The pricing change notice was posted to CME Group's website under Regulation FD disclosure.","The disclosure was reported via Form 8-K items 7.01 and 9.01 on February 2, 2026.","CME Group Inc. (ticker: CME) is the registrant and exchange operator."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118086,"accession_number":"0001156375-25-000204","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-10-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group Q3 2025 earnings reported; press release not provided","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Exhibit 99.1 press release text missing; specific financial figures unavailable.","Press release dated October 22, 2025, covers quarter ended September 30, 2025.","Non-GAAP financial measures included; reconciliation provided in release."],"consensus_eps_estimate":null,"consensus_eps_actual":7.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":4871900000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134532,"accession_number":"0001156375-25-000190","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-09-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CME Group CAO Jack Tobin to retire; will stay through Oct 30, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jack Tobin, Managing Director and Chief Accounting Officer, notified retirement on Sept 9, 2025.","He will remain CAO until Oct 30, 2026, to support transition.","Tobin served as CAO since 2015 and has been with CME for over 23 years.","Retirement is voluntary, not due to any disagreements over accounting or policies.","Company will initiate search for successor; Tobin to assist with transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134531,"accession_number":"0001156375-25-000184","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-07-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"CME Group wins unanimous jury verdict in Class B shareholder lawsuit","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Jury returned unanimous verdict on July 25, 2025 in favor of CME Group and CBOT.","Lawsuit filed January 15, 2014 by certain Class B shareholders alleging breach of contract and implied covenant.","Case was in Circuit Court of Cook County, Chancery Division; putative class action dismissed.","Verdict covers alleged violations of core rights in Certificates of Incorporation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134530,"accession_number":"0001156375-25-000176","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-07-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group Inc. reports financial results for quarter ended June 30, 2025","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["CME Group issued a press release on July 23, 2025 reporting its financial results for the quarter ended June 30, 2025.","The press release includes non-GAAP net income and earnings per share as supplemental financial measures.","Management states that non-GAAP measures provide important supplemental information for comparability with prior reports.","A reconciliation of non-GAAP to GAAP measures is included in the press release."],"consensus_eps_estimate":null,"consensus_eps_actual":5.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":3334300000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151378,"accession_number":"0001156375-25-000120","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-05-09T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"CME Group 2025 annual meeting elects 14 directors, ratifies auditor, approves say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 14 equity directors elected; highest votes for Benesh (280.3M) and Lucas (280.1M); lowest for Lockett (170.0M).","Ratification of Ernst & Young as independent auditor approved: 289.99M for, 21.30M against.","Advisory vote on named executive officer compensation passed: 251.22M for, 36.03M against.","Class B-1, B-2, B-3 director elections lacked quorum; holdover directors continue; one B-2 seat vacant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151377,"accession_number":"0001156375-25-000098","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"CME Group enters $2.25B credit facility maturing 2030, amends $7B clearing facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $2.25B multi-currency revolving credit facility matures April 23, 2030; can be increased to $3.25B.","Facility replaces 2021 credit agreement; proceeds for working capital and general corporate purposes.","CME subsidiary amended its $7B 364-day secured credit facility (expandable to $10B) for clearing house liquidity.","Senior Credit Facility requires minimum consolidated net worth and customary covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151376,"accession_number":"0001156375-25-000093","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-04-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group Q1 2025 earnings released; specifics not included in 8-K","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["CME Group disclosed Q1 2025 financial results via press release on April 23, 2025, but no revenue or EPS figures are available in this filing.","The press release includes both GAAP and non-GAAP measures to supplement financial statements.","Management believes non-GAAP net income and EPS provide better comparability with prior reports."],"consensus_eps_estimate":null,"consensus_eps_actual":2.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":1642300000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151375,"accession_number":"0001193125-25-079725","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-04-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Group and S&P Global sell OSTTRA joint venture to KKR for $3.1B","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total enterprise value of $3.1 billion; proceeds split 50/50 between CME and S&P Global.","Transaction expected to close in second half of 2025, subject to regulatory approvals.","OSTTRA co-CEOs Guy Rowcliffe and John Stewart to remain in their current roles.","KKR to support OSTTRA with increased technology investments and an employee equity program.","OSTTRA, established in 2021, provides post-trade solutions for OTC markets including interest rates, FX, credit, and equities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170270,"accession_number":"0001193125-25-050881","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"CME Group issues $750M 4.400% Notes due 2030 to refinance 2025 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $750M aggregate principal of 4.400% Notes due March 15, 2030 at 99.573% of par.","Interest payable semi-annually on March 15 and September 15, starting September 15, 2025.","Net proceeds, with cash on hand, will redeem all $750M of outstanding 3.00% notes due 2025.","Notes issued under existing indenture with U.S. Bank National Association as trustee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170269,"accession_number":"0001193125-25-045633","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"CME Group issues $750M of 4.400% Notes due 2030 in public offering","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Principal amount $750M at 4.400% interest, maturing 2030.","Underwriters include Barclays, J.P. Morgan, and Wells Fargo.","Underwriting agreement includes customary representations, warranties, and indemnification.","Proceeds intended for general corporate purposes (not explicitly stated in filing)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170268,"accession_number":"0001156375-25-000007","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-02-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q4 2024 financial results; details not available in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release for quarter ended December 31, 2024 furnished as Exhibit 99.1.","Specific financial metrics (revenue, EPS, volumes) not provided in the 8-K body.","Non-GAAP measures included in the press release per Regulation G reconciliation.","Investor should refer to the full press release for performance data."],"consensus_eps_estimate":null,"consensus_eps_actual":9.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":6130100000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187281,"accession_number":"0001193125-24-274928","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Group updates Clearing House collateral fees and client pricing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Changes communicated via Advisory Notice 24-383 and Special Executive Report 9482.","Copies of both notices posted to CME Group's website for review.","Effective date of changes not specified in the filing; details available online."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187280,"accession_number":"0001193125-24-271111","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-12-05T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"CME Group declares $2.1B annual variable dividend ($5.80/share) and $3B share repurchase program","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Annual variable dividend of $5.80 per share ($2.1B total) payable Jan 16, 2025 to holders of record Dec 27, 2024.","Board authorized $3B share repurchase program with no expiration date, subject to market conditions.","Total dividend yield for 2024 is 4.9%, an 8% increase from dividends declared in 2023.","Beginning in 2026, annual variable dividend will align with Q1 regular dividend paid in March rather than at year-end.","Company has paid over $28B in quarterly and variable dividends since adopting the structure in 2012."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187279,"accession_number":"0001193125-24-252912","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CME Group extends CEO Terry Duffy's contract to Dec 2026; appoints new President/CFO and COO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chairman and CEO Terry Duffy's employment extended through December 31, 2026; no changes to base salary, bonus, or LTI target.","CFO Lynne Fitzpatrick promoted to President and CFO; she has been CFO since April 2023.","COO Julie Holzrichter steps down; will remain as advisor. Suzanne Sprague appointed COO and Global Head of Clearing.","Duffy's unvested time-vesting equity awards to vest upon term expiration; performance awards vest based on actual results."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187278,"accession_number":"0001156375-24-000187","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-10-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q3 results; press release not fully extracted","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing indicates Q3 2024 earnings released; press release text not included in this excerpt.","Management uses non-GAAP net income and EPS as supplemental measures.","No specific revenue, EPS, or guidance numbers available in the provided text."],"consensus_eps_estimate":null,"consensus_eps_actual":7.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":4604800000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203784,"accession_number":"0001156375-24-000143","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-07-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group announces Q2 2024 earnings; specific figures not provided in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filed Form 8-K on July 24, 2024 with Item 2.02 for Q2 2024 results.","Press release attached as Exhibit 99.1; actual financial data not included in provided text.","No specific EPS, revenue, or segment details available in the filing excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":4.77,"consensus_revenue_estimate":null,"consensus_revenue_actual":3020400000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203783,"accession_number":"0001193125-24-175987","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-07-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CME Group appoints Mike Dennis as Global Head of Fixed Income effective Aug 5; Dennis resigns from Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mike Dennis joins as Senior Managing Director, Global Head of Fixed Income, reporting to CEO Terry Duffy.","Dennis resigns from CME Board effective July 8; no disagreement with company or board.","Interest rates business grew 14% in Q2 2024, per CEO Terry Duffy.","Tim McCourt named Global Head, Equities, FX, and Alternative Products, reporting to Duffy.","Dennis previously Chief Commercial Officer at ABN AMRO Clearing USA, with 22 years of experience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220366,"accession_number":"0001193125-24-136767","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"CME Group annual meeting: all equity directors elected, Class B quorum not met","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 17 Equity Directors elected; Phyllis Lockett received 103.8M against, highest dissent.","Ratification of Ernst & Young as auditor approved with 289.8M votes for.","Say-on-pay advisory vote passed with 253.1M for and 37.3M against.","Class B-1, B-2, B-3 director elections failed to achieve quorum; incumbents hold over until 2025.","Total shares present 314.5M of 360.0M outstanding (87.3%)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220365,"accession_number":"0001193125-24-113786","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"CME subsidiary amends credit facility to $7B, eligible to increase to $10B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 8 to existing 364-day multi-currency credit facility executed on April 24, 2024.","Facility size: $7 billion, eligible to increase to $10 billion.","Purpose: provide temporary liquidity in event of clearing member default, liquidity constraint, depositary default, or delay in payment systems.","Collateral includes clearing firm guaranty fund contributions and performance bond assets.","Parties: CME (borrower), Bank of America (admin agent), Citibank (collateral agent), and other banks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220364,"accession_number":"0001156375-24-000070","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-04-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q1 2024 results; specific numbers unavailable from filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["CME Group filed Q1 2024 earnings results on April 24, 2024 via Form 8-K.","The accompanying press release (Exhibit 99.1) was not included in the provided text.","No specific revenue, EPS, or segment data can be extracted."],"consensus_eps_estimate":null,"consensus_eps_actual":2.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":1487900000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}